Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium
Advances in antithrombotic therapy, along with an early invasive strategy, have reduced the
incidence of recurrent ischemic events and death in patients with acute coronary syndromes …
incidence of recurrent ischemic events and death in patients with acute coronary syndromes …
Radial versus femoral randomized investigation in ST-segment elevation acute coronary syndrome: the RIFLE-STEACS (Radial Versus Femoral Randomized …
E Romagnoli, G Biondi-Zoccai, A Sciahbasi… - Journal of the American …, 2012 - jacc.org
Objectives: The purpose of this study was to assess whether transradial access for ST-
segment elevation acute coronary syndrome undergoing early invasive treatment is …
segment elevation acute coronary syndrome undergoing early invasive treatment is …
Gender differences in the effects of cardiovascular drugs
An initiation-promotion protocol was used to test the hypothesis that unleaded gasoline (UG)
vapor acts as a liver tumor promoter in female mice under exposure conditions in which UG …
vapor acts as a liver tumor promoter in female mice under exposure conditions in which UG …
Baseline risk of major bleeding in non–ST-segment–elevation myocardial infarction: the CRUSADE (can rapid risk stratification of unstable angina patients suppress …
Background—Treatments for non–ST-segment–elevation myocardial infarction (NSTEMI)
reduce ischemic events but increase bleeding. Baseline prediction of bleeding risk can …
reduce ischemic events but increase bleeding. Baseline prediction of bleeding risk can …
Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: The Task Force for the Diagnosis and Treatment of Non-ST …
JP Bassand, CW Hamm, D Ardissino… - European heart …, 2007 - academic.oup.com
The content of these European Society of Cardiology (ESC) Guidelines has been published
for personal and educational use only. No commercial use is authorized. No part of the ESC …
for personal and educational use only. No commercial use is authorized. No part of the ESC …
Adverse impact of bleeding on prognosis in patients with acute coronary syndromes
Background—The use of multiple antithrombotic drugs and aggressive invasive strategies
has increased the risk of major bleeding in acute coronary syndrome (ACS) patients. It is not …
has increased the risk of major bleeding in acute coronary syndrome (ACS) patients. It is not …
Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a …
R Sørensen, ML Hansen, SZ Abildstrom, A Hvelplund… - The Lancet, 2009 - thelancet.com
Background Combinations of aspirin, clopidogrel, and vitamin K antagonists are widely used
in patients after myocardial infarction. However, data for the safety of combinations are …
in patients after myocardial infarction. However, data for the safety of combinations are …
Effects of radial versus femoral artery access in patients with acute coronary syndromes with or without ST-segment elevation
Objectives: The purpose of this study was to determine the consistency of the effects of radial
artery access in patients with ST-segment elevation myocardial infarction (STEMI) and in …
artery access in patients with ST-segment elevation myocardial infarction (STEMI) and in …
Cytochrome 2C19* 17 allelic variant, platelet aggregation, bleeding events, and stent thrombosis in clopidogrel-treated patients with coronary stent placement
D Sibbing, W Koch, D Gebhard, T Schuster, S Braun… - Circulation, 2010 - Am Heart Assoc
Background—The cytochrome P450 (CYP) 2C19 isoenzyme plays an important role in
clopidogrel metabolization. A recently explored CYP2C19* 17 allelic variant has been linked …
clopidogrel metabolization. A recently explored CYP2C19* 17 allelic variant has been linked …
[HTML][HTML] Bivalirudin for patients with acute coronary syndromes
GW Stone, BT McLaurin, DA Cox… - … England Journal of …, 2006 - Mass Medical Soc
Background Current guidelines for patients with moderate-or high-risk acute coronary
syndromes recommend an early invasive approach with concomitant antithrombotic therapy …
syndromes recommend an early invasive approach with concomitant antithrombotic therapy …